NSE: ORTINLAB - Ortin Laboratories Limited

Rentabilität für sechs Monate: +15.94%
Dividendenrendite: 0.00%

Aktionsplan Ortin Laboratories Limited

de.porti.ru30.0030.0027.0027.0024.0024.0021.0021.0018.0018.0015.0015.00Mai '23Mai '23Jun '23Jun '23Jul '23Jul '23Aug '23Aug '23Sep '23Sep '23Okt '23Okt '23Nov '23Nov '23Dez '23Dez '2320242024Feb '24Feb '24Mär '24Mär '24Apr '24Apr '24Mai '24Mai '24Jun '24Jun '24Jul '24Jul '24Aug '24Aug '24Sep '24Sep '24Okt '24Okt '24
SVG speichern
PNG speichern
CSV speichern

Über das Unternehmen Ortin Laboratories Limited

Ortin Global Limited engages in the manufacture and trading of pharmaceuticals, drugs, and intermediates in India. The company offers various pharmaceutical formulations of tablets, capsules, syrups, and dry powders. It provides formulations, such as anti-diabetics, anti allergics, sedatives and tranquilisers, anti helmenthetics, analgesics and antipyretics, anti-biotics-quinolones, anti-biotic-pencillins, antifungal, cephalosporins, and macrolides; and anti-anginal and cardio vascular, and antifungal products.

weitere details
Its formulations also include chemo therapeutics, antacids and anti ulcerants, anti spasmodics, calcium and iron preparations, anti-arthritic drugs, protein supplements, enzymes, and vitamins, as well as psychiatry, appetizer, gynaec, and anti-retroviral products. In addition, the company offers active pharmaceutical ingredient (API) intermediates, including anti retro viral, anti-diabetics, analgesics and antipyretics, anti-biotics, antifungal, antacids and anti ulcerants, and anti malarials; and manufactures fine chemicals, and grignard and alkali metal products. Further, the company provides services in the areas of process development, process and product characterization, analytical research and development, and assay development; and diagnostic services comprising development of rapid flow kits, assays, and reagents. Additionally, it undertakes long-term contracts for manufacturing intermediates and developing new APIs; and operates as a merchant exporter of pharmaceutical finished formulations. The company was formerly known as Ortin Laboratories Limited and changed its name to Ortin Global Limited in June 2024. Ortin Global Limited was incorporated in 1986 and is headquartered in Hyderabad, India.

ISIN INE749B01020
Industry Pharmaceuticals
Sector Health Care
Валюта inr
Валюта отчета inr
Сайт https://www.ortinlabsindia.com
Цена ао 20.87
Preisänderung pro Tag: 0% (20.87)
Preisänderung pro Woche: -1.32% (21.15)
Preisänderung pro Monat: -2.75% (21.46)
Preisänderung über 3 Monate: +5.24% (19.83)
Preisänderung über sechs Monate: +15.94% (18)
Preisänderung pro Jahr: +5.67% (19.75)
Preisänderung über 3 Jahre: -40.54% (35.1)
Preisänderung über 5 Jahre: +206.41% (6.8112)
Preisänderung seit Jahresbeginn: +2.4% (20.38)

Unterschätzung

Name Bedeutung Grad
P/S 0 0
P/BV 0 0
P/E 0 0
EV/EBITDA 0 0
Gesamt: 2.5

Effizienz

Name Bedeutung Grad
ROA, % 0 0
ROE, % 0 0
Gesamt: 0

Dividenden

Name Bedeutung Grad
Div yield, % 0 0
DSI 0 0
Gesamt: 0

Pflicht

Name Bedeutung Grad
Debt/EBITDA 0 10
Gesamt: 10

Wachstumsimpuls

Name Bedeutung Grad
Rentabilität Revenue, % -96.31 0
Rentabilität Ebitda, % -91.11 0
Rentabilität EPS, % 0 0
Gesamt: 0

Aufsicht Berufsbezeichnung Zahlung Geburtsjahr
Mr. Sanka Murali Krishna Murthy CEO & MD 1959 (66 Jahre)
Mr. Sanka Srinivasa Kumar CFO & Whole Time Director 1965 (60 Jahre)

Adresse: India, Hyderabad, D. No. 1-8-B4 F3 HIG - in Google Maps öffnen, Öffnen Sie Yandex-Karten
Webseite: https://www.ortinlabsindia.com